Privia Health (PRVA) Common Equity (2020 - 2026)

Privia Health's Common Equity history runs 7 years deep, the most recent figure standing at $805.9 million for Q1 2026.

• On a quarterly basis, Common Equity rose 13.58% year-over-year to $805.9 million in Q1 2026; TTM through Mar 2026 was $805.9 million, a 13.58% increase from a year earlier, with the FY2025 full-year figure at $790.9 million, up 15.73% from the prior year.
• Common Equity advanced to $805.9 million in Q1 2026 per PRVA's latest filing, from $790.9 million in the prior quarter.
• Across five years, Common Equity topped out at $805.9 million in Q1 2026 and bottomed at $457.9 million in Q1 2022.
• The 5-year median for Common Equity is $622.8 million (2024), against an average of $628.0 million.
• Across the five-year window, Common Equity surged 206.56% in 2022 and increased 11.91% in 2024, its largest moves.
• Year by year, Common Equity stood at $519.0 million in 2022, then gained by 17.02% to $607.4 million in 2023, then climbed by 12.52% to $683.4 million in 2024, then climbed by 15.73% to $790.9 million in 2025, then grew by 1.89% to $805.9 million in 2026.
• Per Business Quant, the three latest PRVA Common Equity figures stand at $805.9 million (Q1 2026), $790.9 million (Q4 2025), and $762.8 million (Q3 2025).